Patents by Inventor Julien Grassot

Julien Grassot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF ADMINISTERING GAMMA-HYDROXYBUTYRATE COMPOSITIONS WITH DIVALPROEX SODIUM
    Publication number: 20240024263
    Abstract: Oral pharmaceutical compositions of gamma-hydroxybutyrate (GHB) suitable for concomitant administration with a dose of divalproex sodium (DVP) without materially altering the dosage amount of either drug are provided. Also provided are therapeutic uses of the compositions for the treatment of one or more symptoms of narcolepsy.
    Type: Application
    Filed: June 9, 2023
    Publication date: January 25, 2024
    Inventor: Julien Grassot
  • Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
    Patent number: 11583510
    Abstract: Provided herein are methods of administering a once-nightly dosage of gamma-hydroxybutyrate after a high-fat meal.
    Type: Grant
    Filed: February 7, 2022
    Date of Patent: February 21, 2023
    Assignee: Flamel Ireland Limited
    Inventors: Julien Grassot, David Monteith, Hervé Guillard, Claire Mégret, Jean-François Dubuisson
  • METHODS OF ADMINISTERING GAMMA-HYDROXYBUTYRATE COMPOSITIONS WITH DIVALPROEX SODIUM
    Publication number: 20220409561
    Abstract: Oral pharmaceutical compositions of gamma-hydroxybutyrate (GHB) suitable for concomitant administration with a dose of divalproex sodium (DVP) without materially altering the dosage amount of either drug are provided. Also provided are therapeutic uses of the compositions for the treatment of one or more symptoms of narcolepsy.
    Type: Application
    Filed: August 26, 2022
    Publication date: December 29, 2022
    Inventor: Julien Grassot
  • Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
    Patent number: 11504347
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Grant
    Filed: October 8, 2021
    Date of Patent: November 22, 2022
    Assignee: Flamel Ireland Limited
    Inventors: Julien Grassot, Hervé Guillard, Claire Mégret, Jean-François Dubuisson
  • GAMMA-HYDROXYBUTYRATE COMPOSITIONS HAVING IMPROVED PHARMACOKINETICS IN THE FED STATE
    Publication number: 20220313635
    Abstract: Oral pharmaceutical compositions of sodium oxybate having improved pharmacokinetic properties when administered less than two hours after eating are provided, and therapeutic uses thereof.
    Type: Application
    Filed: June 10, 2022
    Publication date: October 6, 2022
    Inventors: Julien Grassot, Cendrine Grangeon, Jordan Dubow
  • Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
    Patent number: 11400065
    Abstract: Oral pharmaceutical compositions of sodium oxybate having improved pharmacokinetic properties when administered less than two hours after eating are provided, and therapeutic uses thereof.
    Type: Grant
    Filed: February 28, 2020
    Date of Patent: August 2, 2022
    Assignee: Flamel Ireland Limited
    Inventors: Julien Grassot, Cendrine Grangeon, Jordan Dubow
  • METHODS OF ADMINISTERING GAMMA-HYDROXYBUTYRATE COMPOSITIONS WITH DIVALPROEX SODIUM
    Publication number: 20220040128
    Abstract: Oral pharmaceutical compositions of gamma-hydroxybutyrate (GHB) suitable for concomitant administration with a dose of divalproex sodium (DVP) without materially altering the dosage amount of either drug are provided. Also provided are therapeutic uses of the compositions for the treatment of one or more symptoms of narcolepsy.
    Type: Application
    Filed: October 15, 2021
    Publication date: February 10, 2022
    Inventor: Julien Grassot
  • METHODS OF ADMINISTERING GAMMA-HYDROXYBUTYRATE COMPOSITIONS WITH DIVALPROEX SODIUM
    Publication number: 20210322348
    Abstract: Oral pharmaceutical compositions of gamma-hydroxybutyrate (GHB) suitable for concomitant administration with a dose of divalproex sodium (DVP) without materially altering the dosage amount of either drug are provided. Also provided are therapeutic uses of the compositions for the treatment of one or more symptoms of narcolepsy.
    Type: Application
    Filed: April 15, 2021
    Publication date: October 21, 2021
    Inventor: Julien Grassot
  • Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
    Patent number: 11000498
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Grant
    Filed: June 4, 2019
    Date of Patent: May 11, 2021
    Assignee: Flamel Ireland Limited
    Inventors: Claire Megret, Herve Guillard, Jean-Francois Dubuisson, Julien Grassot
  • Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
    Patent number: 10925844
    Abstract: Oral pharmaceutical compositions of sodium oxybate having improved pharmacokinetic properties when administered less than two hours after eating are provided, and therapeutic uses thereof.
    Type: Grant
    Filed: August 7, 2020
    Date of Patent: February 23, 2021
    Assignee: Flamel Ireland Limited
    Inventors: Julien Grassot, Cendrine Grangeon, Jordan Dubow
  • GAMMA-HYDROXYBUTYRATE COMPOSITIONS HAVING IMPROVED PHARMACOKINETICS IN THE FED STATE
    Publication number: 20200368187
    Abstract: Oral pharmaceutical compositions of sodium oxybate having improved pharmacokinetic properties when administered less than two hours after eating are provided, and therapeutic uses thereof.
    Type: Application
    Filed: August 7, 2020
    Publication date: November 26, 2020
    Inventors: Julien Grassot, Cendrine Grangeon, Jordan Dubow
  • GAMMA-HYDROXYBUTYRATE COMPOSITIONS HAVING IMPROVED PHARMACOKINETICS IN THE FED STATE
    Publication number: 20200360319
    Abstract: Oral pharmaceutical compositions of sodium oxybate having improved pharmacokinetic properties when administered less than two hours after eating are provided, and therapeutic uses thereof.
    Type: Application
    Filed: August 7, 2020
    Publication date: November 19, 2020
    Inventors: Julien Grassot, Cendrine Grangeon, Jordan Dubow
  • GAMMA-HYDROXYBUTYRATE COMPOSITIONS HAVING IMPROVED PHARMACOKINETICS IN THE FED STATE
    Publication number: 20200276142
    Abstract: Oral pharmaceutical compositions of sodium oxybate having improved pharmacokinetic properties when administered less than two hours after eating are provided, and therapeutic uses thereof.
    Type: Application
    Filed: February 28, 2020
    Publication date: September 3, 2020
    Inventors: Julien Grassot, Cendrine Grangeon, Jordan Dubow
  • MODIFIED RELEASE GAMMA-HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS
    Publication number: 20190282532
    Abstract: Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
    Type: Application
    Filed: June 4, 2019
    Publication date: September 19, 2019
    Inventors: Claire Megret, Herve Guillard, Jean-Francois Dubuisson, Julien Grassot